Position in NTLA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,230,000
+$1,089,100 QoQ
Shares Held
250,000
+2.0% QoQ
Ownership
0.178%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#60
of 330 holders
Holding Since
Jun 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Opaleye Management Inc. holds $678,840,611 across 50 Biotechnology names. NTLA ranks #34 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IRON |
Disc Medicine, Inc.
|
855,000 | $62,534,700 | |
| 2 | URGN |
UroGen Pharma Ltd.
|
1,439,996 | $52,991,852 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
390,000 | $51,764,700 | |
| 4 | MGTX |
MeiraGTx Holdings plc
|
3,550,000 | $47,960,500 | |
| 5 | SLGL |
Sol-Gel Technologies Ltd.
|
500,000 | $37,070,000 | |
| 6 | RZLT |
Rezolute, Inc.
|
6,300,000 | $32,760,000 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
535,000 | $29,392,900 | |
| 8 | IMMX |
Immix Biopharma, Inc.
|
2,345,000 | $24,176,950 |
All Filings in NTLA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,230,000 | 250,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,140,900 | 245,000 | Shares | Sole | 2026-05-15 | |
| 2024-06-30 | $4,878,840 | 218,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,015,050 | 255,000 | Shares | Sole | 2024-05-29 | |
| 2023-12-31 | $3,018,510 | 99,000 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $4,893,600 | 120,000 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||